InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cobuzzi Robert Joseph Jr., Chairman & CEO. Director active across 1 company, notably Diffusion Pharmaceuticals Inc.. In total, 8 reports have been logged. Activity tracked since 18 April 2022. The latest transaction was disclosed on 18 April 2022 (C). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
327 sharesCommon StockSEC:0001437749-22-010718:0
100 shares@ US$25.00100.0% of flowCommon StockSEC:0001437749-22-009234:0
16,350 sharesCommon StockSEC:0001437749-22-002262:0
16,350 sharesCommon StockSEC:0001437749-22-002263
16,350 sharesCommon StockSEC:0001437749-22-002262
16,350 sharesCommon StockSEC:0001437749-22-002263:0
16,350 sharesCommon StockSEC:0001437749-21-025138:0
16,350 sharesCommon StockSEC:0001437749-21-025138
8 of 8 declarations
About Cobuzzi Robert Joseph Jr.
Robert Joseph Cobuzzi Jr. is the Chairman and CEO of Diffusion Pharmaceuticals Inc. He is responsible for the strategic direction of the company, which specializes in developing innovative treatments for critical medical conditions. His leadership aims to advance the company's mission and improve outcomes for patients.
